PatientsVille.com Logo

PatientsVille

Victoza Side Effects

Common Victoza Side Effects


The most commonly reported Victoza side effects (click to view or check a box to report):

Nausea (2264)
Blood Glucose Increased (1054)
Diarrhoea (910)
Decreased Appetite (794)
Vomiting (747)
Weight Decreased (669)
Headache (544)
Pancreatitis (491)
Abdominal Pain Upper (384)
Constipation (364)
Blood Glucose Decreased (330)
Injection Site Haematoma (325)
Dizziness (295)
Pancreatitis Acute (261)
Eructation (261)
Abdominal Discomfort (259)
Malaise (247)
Injection Site Pain (238)
Fatigue (236)
Injection Site Erythema (231)

➢ More



If you or someone in your family has experienced a serious side effect to a health product, you are encouraged to report the experience to your health care professional (e.g. physician, pharmacist). You could also complete a copy of the side effect reporting form or report your side effect to FDA.

Side effects reports are analyzed to discover potential health product safety signals. Some important reactions may take an extremely long time to develop or occur infrequently. Continued monitoring of adverse reactions is thus essential to maintain a comprehensive safety and effectiveness profile of health products.

Victoza Side Effects Reported to FDA

The following Victoza reports list potential signals of serious risks and new safety information that were identified using the FDA Adverse Event Reporting System (FAERS).
FAERS is a database that contains information on adverse event and medication errors reports submitted to FDA by healthcare professionals (such as physicians, pharmacists, nurses and others), consumers (such as patients, family members, layers and others) and manufacturers.


The appearance of Victoza on this list does not mean that FDA has concluded that the drug has the listed risk. It means that FDA has identified a potential safety issue, but it does not mean that FDA has found a causal relationship between the drug and the listed risk.
Intraocular Pressure Increased
This is a report of a 62-year-old male patient (weight: NA) from US, suffering from the following symptoms/conditions: type 2 diabetes mellitus, who was treated with Victoza (dosage: 1.8 Mg, Qd, start time: Nov 26, 2012), combined with:
  • Metformin
  • Lantus
and developed a serious reaction and side effect(s). The consumer presented with:
  • Intraocular Pressure Increased
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Victoza treatment in male patients, resulting in intraocular pressure increased side effect.

Nausea, Weight Decreased, Headache, Pyrexia, Rash Pruritic, Heart Rate Increased
This report suggests a potential Victoza Nausea, Weight Decreased, Headache, Pyrexia, Rash Pruritic, Heart Rate Increased side effect(s) that can have serious consequences. A 64-year-old female patient (weight: NA) from US was diagnosed with the following symptoms/conditions: diabetes mellitus management and used Victoza (dosage: Given Into/under The Skin) starting Oct 10, 2013. Soon after starting Victoza the patient began experiencing various side effects, including:
  • Nausea
  • Weight Decreased
  • Headache
  • Pyrexia
  • Rash Pruritic
  • Heart Rate Increased
Drugs used concurrently: NA.The patient was hospitalized. Although Victoza demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as nausea, may still occur.

Urinary Retention, Cough, Respiratory Tract Congestion
This Urinary Retention, Cough, Respiratory Tract Congestion problem was reported by a consumer or non-health professional from US. A 55-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: weight control,blood glucose increased. On NS this consumer started treatment with Victoza (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Victoza, the patient experienced the following unwanted symptoms/side effects:
  • Urinary Retention
  • Cough
  • Respiratory Tract Congestion
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as urinary retention, may become evident only after a product is in use by the general population.

Pancreatic Carcinoma
This is a report of a 55-year-old female patient (weight: NA) from ES. The patient developed the following symptoms/conditions: type 2 diabetes mellitus and was treated with Victoza (dosage: Unk) starting 201211. Concurrently used drugs: NA.Soon after that, the consumer experienced the following side effects:
  • Pancreatic Carcinoma
This opens a possibility that Victoza treatment could cause the above reactions, including pancreatic carcinoma, and some female subjects may be more susceptible.


Coronary Artery Occlusion, Vomiting
A 62-year-old male patient (weight: NA) from US with the following symptoms/conditions: type 2 diabetes mellitus started Victoza treatment (dosage: 0.6 Mg Qd) on 201310. Soon after starting Victoza treatment, the subject experienced various side effects, including:
  • Coronary Artery Occlusion
  • Vomiting
Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some male patients could be more vulnerable to Victoza.

Pancreatic Carcinoma, Metastases To Liver
A 62-year-old female patient from US (weight: NA) experienced symptoms, such as: NA and was treated with Victoza(dosage: NA). The treatment was initiated on 201302. After that a consumer reported the following side effect(s):
  • Pancreatic Carcinoma
  • Metastases To Liver
Concurrently used drugs, which potentially could have contributed to side effect(s) or affected Victoza efficacy: NA.

Pancreatitis
In this report, Victoza was administered for the following condition: type 2 diabetes mellitus.A 55-year-old male consumer from US (weight: NA) started Victoza treatment (dosage: NA) on Oct 30, 2013.Sometime after starting the treatment, the patient complained of the following side effect(s):
  • Pancreatitis
A possible interaction with other drugs could have contributed to this reaction: NA.The patient was hospitalized.Establishing a causal relationship between a specific drug and consumer's side effects is complex, but it is possible that in this report Victoza treatment could be related to the listed above side effect(s).

Pancreatic Carcinoma, Bile Duct Cancer
This is a report of the following Victoza side effect(s):
  • Pancreatic Carcinoma
  • Bile Duct Cancer
A 79-year-old male patient from US (weight: NA) presented with the following condition: diabetes mellitus and received a treatment with Victoza (dosage: NA) starting: Dec 12, 2012.The following concurrently used drugs could have generated interactions:
  • Bystolic
  • Lipitor
  • Glipizide
  • Imdur
  • Losartan
  • Asa
  • Ranitidine
  • Metformin
The patient was hospitalized.This report suggests that a Victoza treatment could be associated with the listed above side effect(s).

Cerebrovascular Accident, Tachyarrhythmia
This Victoza report was submitted by a 60-year-old male consumer from FR (weight: NA). The patient was diagnosed with: NA and Victoza was administered (dosage: 1.2 Mg, Qd) starting: NS. The consumer developed a set of symptoms:
  • Cerebrovascular Accident
  • Tachyarrhythmia
Other drugs used simultaneously:
  • Metformine
Those unexpected symptoms could be linked to a Victoza treatment, however establishing a potential drug-safety problem requires a more detailed clinical analysis.

Pancreatitis
This is a report of a possible correlation between Victoza use and the following symptoms/side effect(s):
  • Pancreatitis
which could contribute to an assessment of Victoza risk profile.A 74-year-old male consumer from US (weight: NA) was suffering from type 2 diabetes mellitus and was treated with Victoza (dosage: 0.6 Mg, Qd) starting Jan 09, 2014.Other concurrent medications: NA.

Pancreatic Carcinoma Metastatic
A 71-year-old male patient from US (weight: NA) presented with the following symptoms: type 2 diabetes mellitus and after a treatment with Victoza (dosage: 1.2 Mg, Qd) experienced the following side effect(s):
  • Pancreatic Carcinoma Metastatic
The treatment was started on 2003. Victoza was used in combination with the following drugs:
  • Janumet
  • Baby Aspirin (Unk)
  • Baby Aspirin
  • Vitamin D /00107901/ (Unk)
  • Vitamin E (Unk)
  • Fish Oil Omega 3 (Unk)
The patient was hospitalized.This report could alert potential Victoza consumers.

Acute Coronary Syndrome, Pancreatic Carcinoma Metastatic, Hyperglycaemia
In this report, a 65-year-old male patient from CH (weight: NA) was affected by a possible Victoza side effect.The patient was diagnosed with type 2 diabetes mellitus. After a treatment with Victoza (dosage: 1.8 Mg, Qd, start date: NS), the patient experienced the following side effect(s):
  • Acute Coronary Syndrome
  • Pancreatic Carcinoma Metastatic
  • Hyperglycaemia
The following simultaneously used drugs could have led to this reaction:
  • Tresiba (80 U, Qd)
  • Novorapid (Unk)
  • Valsartan (0.5 Tab, Qd (320mg/25mg))
  • Actos (30 Mg, Qd)
  • Pantozol /01263204/ (40 Mg, Bid)
  • Pantozol /01263204/
  • Thioctacid /00213801/ (600 Mg, Qd)
  • Humalog (Unk (according To Outline))
The patient was hospitalized.The findings here stress that side effects should be taken into consideration when evaluating a Victoza treatment.

Pancreatic Carcinoma Metastatic
This is a report of a 65-year-old male patient from US (weight: NA), who used Victoza (dosage: 1.8 Mg, Qd) for a treatment of type 2 diabetes mellitus. After starting a treatment on Aug 29, 2012, the patient experienced the following side effect(s):
  • Pancreatic Carcinoma Metastatic
The following drugs could possibly have interacted with the Victoza treatment
  • Iron (27 Mg, Unk)
  • Vitamin B12 /00056201/ (1000 ?g, Qd)
  • Aspirin E.c (81 Mg, Qd)
  • Vitamin D3 (2000 Iu, Bid)
  • Fish Oil (120 Mg-180 Mg, Qd)
  • Glucosamine Chondroitin /01430901/ (600 Mg-750 Mg, Qd)
  • Nitrostat (0.4 Mg, Prn)
  • Amlodipine Besylate (2.5 Mg, Qd)
Taken together, these observations suggest that a Victoza treatment could be related to side effect(s), such as Pancreatic Carcinoma Metastatic.

Stent Placement
This stent placement side effect was reported by a consumer or non-health professional from US. A 59-year-old female patient (weight:NA) experienced the following symptoms/conditions: type 2 diabetes mellitus. The patient was prescribed Victoza (dosage: 1.8 Mg Daily), which was started on 2008. Concurrently used drugs: NA. When starting to take Victoza the consumer reported the following symptoms:
  • Stent Placement
These side effects may potentially be related to Victoza.

Stent Placement
This is a Victoza side effect report of a 59-year-old female patient (weight:NA) from US, suffering from the following symptoms/conditions: type 2 diabetes mellitus, who was treated with Victoza (dosage:1.8 Mg Daily, start time: 2008), combined with: NA., and developed a serious reaction and a stent placement side effect. The patient presented with:
  • Stent Placement
which developed after the beginning of treatment. This side effect report can indicate a possible existence of increased vulnerability to Victoza treatment in female patients suffering from type 2 diabetes mellitus, resulting in stent placement.

Cholangiocarcinoma, Metastases To Liver
This report suggests a potential Victoza cholangiocarcinoma side effect(s) that can have serious consequences. A 51-year-old female patient from GB (weight:NA) was diagnosed with the following health condition(s): NA and used Victoza (dosage: 1.2 Mg) starting 2007. Soon after starting Victoza the patient began experiencing various side effects, including:
  • Cholangiocarcinoma
  • Metastases To Liver
Drugs used concurrently:
  • Sitagliptin (100 Mg)
  • Buscopan (Unk)
  • Chlorpromazine (75 Mg)
  • Humulin I (Unk)
  • Omeprazole (20 Mg)
  • Pregabalin (75 Mg)
Although Victoza demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as cholangiocarcinoma, may still occur.

Diarrhoea, Malaise
This diarrhoea problem was reported by a pharmacist from GB. A 67-year-old male patient (weight: NA) was diagnosed with the following medical condition(s): NA.On Dec 06, 2013 a consumer started treatment with Victoza (dosage: Unk). The following drugs/medications were being taken at the same time:
  • Amitriptyline (Unk)
  • Aspirin (Unk)
  • Atorvastatin (Unk)
  • Ezetrol (Unk)
  • Gliclazide (Unk)
  • Lansoprazole (Unk)
  • Lercanidipine (Unk)
  • Metformin (Unk)
When commencing Victoza, the patient experienced the following unwanted symptoms /side effects:
  • Diarrhoea
  • Malaise
Although all drugs are carefully tested before they are licensed for use, they carry potential side effect risks. Some side effects, such as diarrhoea, may become evident only after a product is in use by the general population.

Blood Triglycerides Increased, Pancreatitis Acute
This is a Victoza side effect report of a 50-year-old female patient (weight: NA) from FR. The patient developed the following symptoms/conditions: type 2 diabetes mellitus,dyslipidaemia and was treated with Victoza (dosage: 1.80 Mg, Qd) starting 2008. Concurrently used drugs:
  • Omacor (3 Df, Qd)
  • Metformin (1700 Mg, Qd)
  • Lasilix /00032601/ (40 Mg, Qd)
  • Triatec /00116401/ (5 Mg, Qd)
  • Kaleorid (1000 Mg, Qd)
  • Kardegic (75 Mg, Qd)
  • Cardensiel (2.50 Mg, Qd)
  • Nureflex (1200 Mg, Qd)
Soon after that, the consumer experienced the following of symptoms:
  • Blood Triglycerides Increased
  • Pancreatitis Acute
The patient was hospitalized. This opens a possibility that Victoza could cause blood triglycerides increased and that some female patients may be more susceptible.

Pancreatic Carcinoma
A 63-year-old male patient (weight: NA) from US with the following symptoms: type 2 diabetes mellitus started Victoza treatment (dosage: 18mg/3ml Once Daily) on 2011. Soon after starting Victoza treatment, the consumer experienced several side effects, including:
  • Pancreatic Carcinoma
. Concurrently used drugs: NA.The patient was hospitalized. This finding indicates that some patients can be more vulnerable to developing Victoza side effects, such as pancreatic carcinoma.

Cerebrovascular Accident
This cerebrovascular accident side effect was reported by a health professional from US. A 72-year-old female patient (weight:NA) experienced the following symptoms/conditions: type 2 diabetes mellitus.The patient was prescribed Victoza (dosage: 1.8 Mg, Qd), which was started on Jul 11, 2013. Concurrently used drugs: NA..When starting to take Victoza the consumer reported symptoms, such as:
  • Cerebrovascular Accident
These side effects may potentially be related to Victoza. The patient was hospitalized.

Pancreatic Carcinoma Metastatic, Off Label Use
This is a report of a 62-year-old male patient (weight: NA) from US, suffering from the following symptoms/conditions: diabetes mellitus,obesity, who was treated with Victoza (dosage: 1.8 Mg, Qd, start time: 201203), combined with: NA. and developed a serious reaction and side effect(s). The consumer presented with:
  • Pancreatic Carcinoma Metastatic
  • Off Label Use
which developed after the beginning of treatment. This case can indicate the possible existence of increased vulnerability to Victoza treatment in male patients, resulting in pancreatic carcinoma metastatic side effect. The patient was hospitalized.

International Normalised Ratio Decreased, Off Label Use
This report suggests a potential Victoza Injection International Normalised Ratio Decreased, Off Label Use side effect(s) that can have serious consequences. A 49-year-old male patient (weight: NA) from GB was diagnosed with the following symptoms/conditions: diabetes mellitus,weight control and used Victoza Injection (dosage: 0.6 Mg, Qd) starting Jul 07, 2011. Soon after starting Victoza Injection the patient began experiencing various side effects, including:
  • International Normalised Ratio Decreased
  • Off Label Use
Drugs used concurrently: NA. Although Victoza Injection demonstrated significant improvements in a number of clinically relevant cases, troublesome symptoms, such as international normalised ratio decreased, may still occur.

Hyperamylasaemia, Hyperlipasaemia, Abdominal Pain
This Hyperamylasaemia, Hyperlipasaemia, Abdominal Pain problem was reported by a health professional from FR. A 66-year-old female patient (weight: NA) was diagnosed with the following symptoms/conditions: type 2 diabetes mellitus. On 2013 this consumer started treatment with Victoza (dosage: NA). The following drugs were being taken at the same time: NA. When commencing Victoza, the patient experienced the following unwanted symptoms/side effects:
  • Hyperamylasaemia
  • Hyperlipasaemia
  • Abdominal Pain
Although all drugs are carefully tested before they are licensed for use, they carry side effect risks. Some side effects, such as hyperamylasaemia, may become evident only after a product is in use by the general population.

Hyperamylasaemia, Hyperlipasaemia
This is a report of a 57-year-old male patient (weight: NA) from FR. The patient developed the following symptoms/conditions: type 2 diabetes mellitus and was treated with Victoza (dosage: 1.8 Mg, Qd) starting Mar 06, 2012. Concurrently used drugs:
  • Novonorm
  • Metformine (1000 Mg)
  • Inegy (10/20)
  • Allopurinol
  • Coversyl /00790702/
  • Temerit
  • Kardegic
Soon after that, the consumer experienced the following side effects:
  • Hyperamylasaemia
  • Hyperlipasaemia
This opens a possibility that Victoza treatment could cause the above reactions, including hyperamylasaemia, and some male subjects may be more susceptible.

Adenocarcinoma Pancreas
A 72-year-old female patient (weight: NA) from US with the following symptoms/conditions: type 2 diabetes mellitus started Victoza treatment (dosage: Unk) on 200701. Soon after starting Victoza treatment, the subject experienced various side effects, including:
  • Adenocarcinoma Pancreas
Concurrently used drugs:
  • Byetta (Unk)
  • Januvia (Unk)
  • Janumet (Unk)
  • Bydureon (Unk)
The patient was hospitalized. This finding indicates that some female patients could be more vulnerable to Victoza.

  3 of 359 



Top 10 Victoza Side Effects for Women

Women Side EffectsReports
Nausea 1586
Blood Glucose Increased 600
Diarrhoea 594
Vomiting 536
Decreased Appetite 496
Headache 405
Weight Decreased 403
Pancreatitis 261
Abdominal Pain Upper 249
Constipation 246

Top 10 Victoza Side Effects for Men

Men Side EffectsReports
Nausea 671
Blood Glucose Increased 453
Diarrhoea 313
Decreased Appetite 297
Weight Decreased 264
Pancreatitis 222
Vomiting 208
Headache 139
Abdominal Pain Upper 134
Pancreatitis Acute 132

Keep Track of Side Effects

Note Your Observations

It is really important to keep of your symptoms, right from the time you start a new medicine. You can do it any way you prefer: in a notebook, in a computer file or using our online tool. You should also note down any other medicines you are taking at the same time, because there could be an interaction between these medicines.

Why Your Notes are Important

Your notes could be helpful in several ways:

  • You can use them to remind you of details that may alert your health care professional(s) to a problem
  • You will have a record to refer to in the future, in case you are ever prescribed the same medicine again

  • Log Form

    You can use the following log form to write down important information, like the date and time you experienced a side effect and your symptoms, how strong the symptoms were, and any other medicines you were using.

    Medicine Name and Dosage:
    Side Effects Scale Date & Time Other Medicine(s) or Treatment(s)
    Scale: 1 = very mild to 10 = very bad

    You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


    Discuss Victoza Side Effects

    Did You Have a Victoza Side Effect?

    Yes, Severe
    Yes, Moderate
    Yes, Minor
    No

    How Effective is Victoza for You?

    Exceeded Expectations
    Effective
    Somewhat Effective
    Not Effective

    Victoza Safety Alerts, Active Ingredients, Usage Information

    NDC0169-4060
    TypeHUMAN PRESCRIPTION DRUG
    Proprietary NameVictoza
    Nameliraglutide (rDNA origin) injection
    Dosage FormINJECTION, SOLUTION
    RouteSUBCUTANEOUS
    On market since20100125
    LabelerNovo Nordisk
    Active Ingredient(s)LIRAGLUTIDE
    Strength(s)6
    Unit(s)mg/mL
    Pharma ClassGLP-1 Receptor Agonist [EPC],Glucagon-Like Peptide 1 [Chemical/Ingredient],Glucagon-like Peptide-1 (

    More About Victoza

    Side Effects reported to FDA: 8970

    Victoza safety alerts: 2011

    Reported deaths: 157

    Reported hospitalizations: 1313

    Latest Victoza clinical trials